Lineage Cell Therapeutics, Inc. (LCTX) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
LCTX Historical Performance
Short-Term Returns
LCTX Stock Price Trajectory (2011–2026)
As of May 8, 2026, Lineage Cell Therapeutics, Inc. (LCTX) trades at $1.37, representing a +208.6% return over the past year. The stock has delivered a -50.0% total return over five years (-12.9% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $27.00 on October 31, 1997. From this peak, LCTX has corrected -94.9%, currently trading 13% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers FATE (+143.0% 1Y), NTLA (+88.1% 1Y), and BEAM (+93.9% 1Y), LCTX has outperformed the peer group average. Compare LCTX vs FATE →
LCTX Historical Price Data (2025–2026)
Showing 30 of 3,650 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.44 | 1.45 | 1.36 | 1.37 | 1.50M | -4.20% |
| 2026-05-06 | 1.49 | 1.49 | 1.41 | 1.43 | 801K | -2.05% |
| 2026-05-05 | 1.46 | 1.50 | 1.45 | 1.46 | 1.17M | +2.82% |
| 2026-05-04 | 1.50 | 1.52 | 1.40 | 1.42 | 2.76M | -7.19% |
| 2026-05-01 | 1.50 | 1.55 | 1.49 | 1.53 | 1.36M | +1.32% |
| 2026-04-30 | 1.47 | 1.52 | 1.46 | 1.51 | 1.79M | +3.42% |
| 2026-04-29 | 1.57 | 1.58 | 1.46 | 1.46 | 2.27M | -6.41% |
| 2026-04-28 | 1.54 | 1.66 | 1.53 | 1.56 | 1.30M | +0.65% |
| 2026-04-27 | 1.57 | 1.60 | 1.54 | 1.55 | 612K | 0.00% |
| 2026-04-24 | 1.57 | 1.58 | 1.54 | 1.55 | 807K | -0.64% |
| 2026-04-23 | 1.64 | 1.66 | 1.54 | 1.56 | 1.05M | -4.29% |
| 2026-04-22 | 1.65 | 1.69 | 1.62 | 1.63 | 431K | -0.91% |
| 2026-04-21 | 1.67 | 1.68 | 1.63 | 1.65 | 820K | -0.30% |
| 2026-04-20 | 1.70 | 1.70 | 1.65 | 1.65 | 874K | -3.51% |
| 2026-04-17 | 1.65 | 1.75 | 1.64 | 1.71 | 1.98M | +4.27% |
| 2026-04-16 | 1.62 | 1.64 | 1.56 | 1.64 | 862K | +0.61% |
| 2026-04-15 | 1.58 | 1.69 | 1.58 | 1.63 | 1.80M | +2.52% |
| 2026-04-14 | 1.55 | 1.60 | 1.55 | 1.59 | 740K | +5.30% |
| 2026-04-13 | 1.48 | 1.53 | 1.45 | 1.51 | 927K | +2.03% |
| 2026-04-10 | 1.51 | 1.53 | 1.46 | 1.48 | 846K | -0.67% |
| 2026-04-09 | 1.52 | 1.56 | 1.49 | 1.49 | 990K | -3.25% |
| 2026-04-08 | 1.63 | 1.65 | 1.53 | 1.54 | 1.21M | +0.65% |
| 2026-04-07 | 1.52 | 1.56 | 1.50 | 1.53 | 1.03M | -0.65% |
| 2026-04-06 | 1.54 | 1.60 | 1.52 | 1.54 | 1.24M | -1.28% |
| 2026-04-02 | 1.54 | 1.60 | 1.54 | 1.56 | 578K | -1.89% |
| 2026-04-01 | 1.62 | 1.63 | 1.57 | 1.59 | 779K | +0.63% |
| 2026-03-31 | 1.48 | 1.59 | 1.47 | 1.58 | 1.02M | +7.48% |
| 2026-03-30 | 1.50 | 1.50 | 1.46 | 1.47 | 891K | -1.34% |
| 2026-03-27 | 1.52 | 1.54 | 1.48 | 1.49 | 1.00M | -2.61% |
| 2026-03-26 | 1.53 | 1.57 | 1.51 | 1.53 | 699K | -1.29% |
See LCTX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LCTX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LCTX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLCTX — Frequently Asked Questions
Quick answers to the most common questions about buying LCTX stock.
How has LCTX stock performed recently?
LCTX returned +208.6% over the past year, beating its 5-year annualized CAGR of -12.9%. The stock trades below its 200-day moving average, confirming the uptrend.
What is LCTX's all-time high price?
Lineage Cell Therapeutics, Inc. reached $27.00 on 1997-10-31. The 52-week high is $2.09. Current 1-year return of +208.6% places the stock closer to historical peaks.
Where can I download LCTX historical price data?
This page provides LCTX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.